Global Pneumococcal Vaccines Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Sep-2018   |    Format : PDF   |    Pages : 106
This report studies the global market size of Pneumococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Vaccines in these regions.
This research report categorizes the global Pneumococcal Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Pneumococcal Vaccines market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Pneumococcal Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pneumococcal Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pneumococcal Vaccines include
    Pfizer
    Sanofi
    GSK
    Merck
    Eli Lilly
    AstraZeneca
    Abera
    S K Chemicals
    Beijing Minhai Biotechnology
    Baxter
    Biken
    Celgene Corporation
    Panacea Biotec
    Serum Institute of India
    Genentech
    Genocea Biosciences
    ImmunoBiology
    Lupin
    Nuron Biotech
    Biogen
    Valneva Austria
    Sinovac

Market Size Split by Type
    PPSV 23
    PCV 7/13
    PCV 10
Market Size Split by Application
    For Infants
    For Children (2-10)
    For Person (10-64)
    For The Old (=65)

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Pneumococcal Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Pneumococcal Vaccines market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Pneumococcal Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Pneumococcal Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Pneumococcal Vaccines submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pneumococcal Vaccines are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Pneumococcal Vaccines Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Type
        1.4.2 PPSV 23
        1.4.3 PCV 7/13
        1.4.4 PCV 10
    1.5 Market by Application
        1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by Application
        1.5.2 For Infants
        1.5.3 For Children (2-10)
        1.5.4 For Person (10-64)
        1.5.5 For The Old (=65)
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Pneumococcal Vaccines Market Size
        2.1.1 Global Pneumococcal Vaccines Revenue 2016-2025
        2.1.2 Global Pneumococcal Vaccines Sales 2016-2025
    2.2 Pneumococcal Vaccines Growth Rate by Regions
        2.2.1 Global Pneumococcal Vaccines Sales by Regions
        2.2.2 Global Pneumococcal Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Pneumococcal Vaccines Sales by Manufacturers
        3.1.1 Pneumococcal Vaccines Sales by Manufacturers
        3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers
        3.1.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
    3.2 Pneumococcal Vaccines Revenue by Manufacturers
        3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2016-2018)
        3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2016-2018)
    3.3 Pneumococcal Vaccines Price by Manufacturers
    3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
        3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Pneumococcal Vaccines Product Category
        3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Pneumococcal Vaccines Sales by Type
    4.2 Global Pneumococcal Vaccines Revenue by Type
    4.3 Pneumococcal Vaccines Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Pneumococcal Vaccines Breakdown Data by Application

6 North America
    6.1 North America Pneumococcal Vaccines by Countries
        6.1.1 North America Pneumococcal Vaccines Sales by Countries
        6.1.2 North America Pneumococcal Vaccines Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Pneumococcal Vaccines by Type
    6.3 North America Pneumococcal Vaccines by Application
    6.4 North America Pneumococcal Vaccines by Company

7 Europe
    7.1 Europe Pneumococcal Vaccines by Countries
        7.1.1 Europe Pneumococcal Vaccines Sales by Countries
        7.1.2 Europe Pneumococcal Vaccines Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Pneumococcal Vaccines by Type
    7.3 Europe Pneumococcal Vaccines by Application
    7.4 Europe Pneumococcal Vaccines by Company

8 Asia Pacific
    8.1 Asia Pacific Pneumococcal Vaccines by Countries
        8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries
        8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Pneumococcal Vaccines by Type
    8.3 Asia Pacific Pneumococcal Vaccines by Application
    8.4 Asia Pacific Pneumococcal Vaccines by Company

9 Central & South America
    9.1 Central & South America Pneumococcal Vaccines by Countries
        9.1.1 Central & South America Pneumococcal Vaccines Sales by Countries
        9.1.2 Central & South America Pneumococcal Vaccines Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Pneumococcal Vaccines by Type
    9.3 Central & South America Pneumococcal Vaccines by Application
    9.4 Central & South America Pneumococcal Vaccines by Company

10 Middle East and Africa
    10.1 Middle East and Africa Pneumococcal Vaccines by Countries
        10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries
        10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Pneumococcal Vaccines by Type
    10.3 Middle East and Africa Pneumococcal Vaccines by Application
    10.4 Middle East and Africa Pneumococcal Vaccines by Company

11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.1.4 Pneumococcal Vaccines Product Description
        11.1.5 Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.2.4 Pneumococcal Vaccines Product Description
        11.2.5 Recent Development
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.3.4 Pneumococcal Vaccines Product Description
        11.3.5 Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.4.4 Pneumococcal Vaccines Product Description
        11.4.5 Recent Development
    11.5 Eli Lilly
        11.5.1 Eli Lilly Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.5.4 Pneumococcal Vaccines Product Description
        11.5.5 Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.6.4 Pneumococcal Vaccines Product Description
        11.6.5 Recent Development
    11.7 Abera
        11.7.1 Abera Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.7.4 Pneumococcal Vaccines Product Description
        11.7.5 Recent Development
    11.8 S K Chemicals
        11.8.1 S K Chemicals Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.8.4 Pneumococcal Vaccines Product Description
        11.8.5 Recent Development
    11.9 Beijing Minhai Biotechnology
        11.9.1 Beijing Minhai Biotechnology Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.9.4 Pneumococcal Vaccines Product Description
        11.9.5 Recent Development
    11.10 Baxter
        11.10.1 Baxter Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Pneumococcal Vaccines
        11.10.4 Pneumococcal Vaccines Product Description
        11.10.5 Recent Development
    11.11 Biken
    11.12 Celgene Corporation
    11.13 Panacea Biotec
    11.14 Serum Institute of India
    11.15 Genentech
    11.16 Genocea Biosciences
    11.17 ImmunoBiology
    11.18 Lupin
    11.19 Nuron Biotech
    11.20 Biogen
    11.21 Valneva Austria
    11.22 Sinovac

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Pneumococcal Vaccines Raw Material
        13.1.2 Pneumococcal Vaccines Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Pneumococcal Vaccines
    Figure Global Pneumococcal Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Pneumococcal Vaccines Production Market Share by Types (Product Category) in 2017
    Figure PPSV 23 Product Picture
    Table Major Manufacturers of PPSV 23
    Figure PCV 7/13 Product Picture
    Table Major Manufacturers of PCV 7/13
    Figure PCV 10 Product Picture
    Table Major Manufacturers of PCV 10
    Table Global Pneumococcal Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure For Infants
    Figure For Children (2-10)
    Figure For Person (10-64)
    Figure For The Old (=65)
    Figure Pneumococcal Vaccines Report Years Considered
    Figure Global Pneumococcal Vaccines Market Size 2016-2025 (Million US$)
    Figure Global Pneumococcal Vaccines Sales 2016-2025 (K Units)
    Table Global Pneumococcal Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Pneumococcal Vaccines Sales by Regions 2016-2025 (K Units)
    Table Global Pneumococcal Vaccines Sales Market Share by Regions 2016-2025
    Figure Global Pneumococcal Vaccines Sales Market Share by Regions 2016-2025
    Figure 2017 Global Pneumococcal Vaccines Sales Market Share by Regions
    Table Global Pneumococcal Vaccines Revenue by Regions 2016-2025 (Million US$)
    Table Global Pneumococcal Vaccines Revenue Market Share by Regions 2016-2025
    Figure Global Pneumococcal Vaccines Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Pneumococcal Vaccines Revenue Market Share by Regions
    Table Global Pneumococcal Vaccines Sales by Manufacturers (2016-2018) (K Units)
    Table Global Pneumococcal Vaccines Sales Share by Manufacturers (2016-2018)
    Figure Global Pneumococcal Vaccines Sales Share by Manufacturers in 2017
    Table Pneumococcal Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
    Table Pneumococcal Vaccines Revenue Share by Manufacturers (2016-2018)
    Figure Pneumococcal Vaccines Value Share by Manufacturers in 2017
    Table Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Pneumococcal Vaccines Price (2016-2018) (USD/Unit)
    Table Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Pneumococcal Vaccines Product Category
    Table Date of International Manufacturers Enter into Pneumococcal Vaccines Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table Global Pneumococcal Vaccines Sales Share by Type (2016-2025)
    Figure Global Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure Global Pneumococcal Vaccines Sales Market Share by Type in 2017
    Table Global Pneumococcal Vaccines Revenue by Type (2016-2025) (Million US$)
    Table Global Pneumococcal Vaccines Revenue Share by Type (2016-2025)
    Figure Global Pneumococcal Vaccines Revenue Market Share by Type (2016-2025)
    Figure Global Pneumococcal Vaccines Revenue Market Share by Type in 2017
    Table Pneumococcal Vaccines Price by Type 2013-2018 (USD/Unit)
    Table Global Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table Global Pneumococcal Vaccines Sales Share by Application (2016-2025)
    Figure Global Sales Pneumococcal Vaccines Market Share by Application (2016-2025)
    Figure Global Sales Pneumococcal Vaccines Market Share by Application (2016-2025)
    Figure North America Pneumococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
    Figure North America Pneumococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Pneumococcal Vaccines Sales by Countries (2016-2025) (K Units)
    Table North America Pneumococcal Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Pneumococcal Vaccines Sales Market Share by Countries
    Table North America Pneumococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table North America Pneumococcal Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Pneumococcal Vaccines Revenue Market Share by Countries
    Figure United States Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure United States Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table North America Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 North America Pneumococcal Vaccines Market Share by Type
    Table North America Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table North America Pneumococcal Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 North America Pneumococcal Vaccines Market Share by Application
    Table North America Pneumococcal Vaccines Sales by Company (2016-2018) (K Units)
    Table North America Pneumococcal Vaccines Sales Market Share by Company (2016-2018)
    Figure North America Pneumococcal Vaccines Sales Market Share by Company in 2017
    Figure Europe Pneumococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Pneumococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Pneumococcal Vaccines Sales by Countries (2016-2025) (K Units)
    Table Europe Pneumococcal Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Pneumococcal Vaccines Sales Market Share by Countries
    Table Europe Pneumococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Europe Pneumococcal Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Pneumococcal Vaccines Revenue Market Share by Countries
    Figure Germany Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (K Units)
    Figure France Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure France Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure UK Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table Europe Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Pneumococcal Vaccines Market Share by Type
    Table Europe Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table Europe Pneumococcal Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Pneumococcal Vaccines Market Share by Application
    Table Europe Pneumococcal Vaccines Sales by Company (2016-2018) (K Units)
    Table Europe Pneumococcal Vaccines Sales Market Share by Company (2016-2018)
    Figure Europe Pneumococcal Vaccines Sales Market Share by Company in 2017
    Figure Asia Pacific Pneumococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Pneumococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Pneumococcal Vaccines Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Vaccines Sales Market Share by Countries
    Table Asia Pacific Pneumococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Pneumococcal Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Vaccines Revenue Market Share by Countries
    Figure China Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure China Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure India Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Vaccines Market Share by Type
    Table Asia Pacific Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Pneumococcal Vaccines Market Share by Application
    Table Asia Pacific Pneumococcal Vaccines Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Pneumococcal Vaccines Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Pneumococcal Vaccines Sales Market Share by Company in 2017
    Figure Central & South America Pneumococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Pneumococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Pneumococcal Vaccines Sales by Countries (2016-2025) (K Units)
    Table Central & South America Pneumococcal Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Pneumococcal Vaccines Sales Market Share by Countries
    Table Central & South America Pneumococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Pneumococcal Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Pneumococcal Vaccines Revenue Market Share by Countries
    Figure Brazil Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table Central & South America Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Pneumococcal Vaccines Market Share by Type
    Table Central & South America Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table Central & South America Pneumococcal Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Pneumococcal Vaccines Market Share by Application
    Table Central & South America Pneumococcal Vaccines Sales by Company (2016-2018) (K Units)
    Table Central & South America Pneumococcal Vaccines Sales Market Share by Company (2016-2018)
    Figure Central & South America Pneumococcal Vaccines Sales Market Share by Company in 2017
    Figure Middle East and Africa Pneumococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Pneumococcal Vaccines Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Vaccines Sales Market Share by Countries
    Table Middle East and Africa Pneumococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Countries
    Figure GCC Countries Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Pneumococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Pneumococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Pneumococcal Vaccines Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Vaccines Market Share by Type
    Table Middle East and Africa Pneumococcal Vaccines Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Pneumococcal Vaccines Market Share by Application
    Table Middle East and Africa Pneumococcal Vaccines Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Pneumococcal Vaccines Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Pneumococcal Vaccines Sales Market Share by Company in 2017
    Table Pfizer Company Details
    Table Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pfizer Recent Development
    Table Sanofi Company Details
    Table Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table GSK Company Details
    Table GSK Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table GSK Recent Development
    Table Merck Company Details
    Table Merck Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Merck Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Eli Lilly Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AstraZeneca Recent Development
    Table Abera Company Details
    Table Abera Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Abera Recent Development
    Table S K Chemicals Company Details
    Table S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table S K Chemicals Recent Development
    Table Beijing Minhai Biotechnology Company Details
    Table Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Beijing Minhai Biotechnology Recent Development
    Table Baxter Company Details
    Table Baxter Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Baxter Recent Development
    Table Biken Company Details
    Table Celgene Corporation Company Details
    Table Panacea Biotec Company Details
    Table Serum Institute of India Company Details
    Table Genentech Company Details
    Table Genocea Biosciences Company Details
    Table ImmunoBiology Company Details
    Table Lupin Company Details
    Table Nuron Biotech Company Details
    Table Biogen Company Details
    Table Valneva Austria Company Details
    Table Sinovac Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Pneumococcal Vaccines Value Chain
    Table Typical Suppliers of Key Pneumococcal Vaccines Raw Material
    Table Pneumococcal Vaccines Customers List
    Table Pneumococcal Vaccines Sales Channels
    Table Pneumococcal Vaccines Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...